Skip to content
Open access

Correlation of VEGF and Ki-67 Expression with Histopathological Features and WHO Grade in Meningioma: A Cross-sectional Study.

Aug 2026 · Asian Pacific Journal of Cancer Prevention · Vol 27 8, pp. 2861-2870 · 0 citations · 30 references
Medicine

TL;DR

Both VEGF and Ki-67 are associated with aggressive histopathology in meningiomas, and their combined evaluation provides a valuable molecular adjunct to conventional histology, potentially refining risk stratification, particularly in borderline cases.

Abstract

Background

Meningiomas, the most common primary central nervous system tumors, exhibit variable clinical behavior. While World Health Organization (WHO) grading is standard, complementary biomarkers are needed to refine prognostication. Vascular Endothelial Growth Factor (VEGF) and Ki-67 are potential indicators of angiogenesis and proliferation that may enhance diagnostic precision. This study aimed to evaluate the correlation between VEGF and Ki-67 expression with the histopathological features and WHO 2021 grade of meningiomas.

Methods

In this cross-sectional study, 73 formalin-fixed, paraffin-embedded meningioma specimens were analyzed. Tumors were graded per WHO 2021 criteria. VEGF expression (H-score) and Ki-67 labeling index (LI) were assessed via immunohistochemistry and correlated with histopathological features, including mitotic activity and brain invasion. Statistical analysis utilized chi-square, Kruskal-Wallis, and Spearman tests (p<0.05).

Results

Most tumors were WHO Grade I (83.6%). Higher VEGF expression was significantly associated with mitotic activity, brain invasion, and hypercellularity, and was increased in high-grade (WHO II-III) meningiomas. Ki-67 labeling index showed a significant positive correlation with WHO grade and other aggressive histopathological features.

Conclusion

Both VEGF and Ki-67 are associated with aggressive histopathology in meningiomas. Ki-67 expression strongly correlates with overall WHO grade, whereas VEGF is more indicative of specific invasive traits. Their combined evaluation provides a valuable molecular adjunct to conventional histology, potentially refining risk stratification, particularly in borderline cases. However, interpretation of these findings is limited by the single-center, cross-sectional design and the relatively small number of high-grade and invasive cases.

Read PDF

Similar papers

Open access Sep 2026

Clinicopathological Study of CK19 Expression in Head and Neck Squamous Cell Carcinoma and Its Association with Tumor Grading: A Cross-Sectional Study.

CK19 expression is significantly associated with poor tumor differentiation in HNSCC, particularly by WHO grading, supporting its potential as a prognostic biomarker that may enhance grading accuracy and inform treatment strategies.

Akhil Kumar, Vibhuti Thukral, R. Kalra · 0 citations
Open access Aug 2026

Proliferation patterns across meningioma locations: A WHO grade-based analysis.

Meningiomas are the most common primary central nervous system tumors and their biological behavior is closely related to histopathological grade and proliferative activity. This study investigated the associations between World Health Organization (WHO) grade, tumor location, mitotic activity, and Ki-67 labeling index...

Neşe Yeldir, Mohammad Sargolzaeimoghaddam, Maral Sargolzaeimoghaddam et al. · 0 citations
Open access Aug 2026

IDH1 Immunoexpression and Ki-67 Labeling Index in Glioma and Their Correlation with Clinicopathological Parameters

Abstract Background The most common primary malignant tumors of the central nervous system are gliomas, and the most frequent isocitrate dehydrogenase (IDH) mutation in gliomas is IDH1 R132H, rather than IDH2 mutations. The proliferative marker Ki-67 has been widely studied in gliomas; however, its relationship with ID...

Tulasi Satyendra Boddeda, J. Bharti, P. Elhence et al. · 0 citations
Open access Sep 2026

EVALUATION OF IMMUNOHISTOCHEMICAL BIOMARKERS (KI-67, P53, AND HER2) IN BREAST CARCINOMA: CORRELATION WITH TUMOR GRADE AND PROGNOSTIC OUTCOMES

Background: Breast carcinoma had remained one of the most common malignancies affecting women, and accurate assessment of tumor biology had been essential for predicting disease behavior and guiding treatment. Immunohistochemical biomarkers such as Ki-67, p53, and HER2 had provided valuable information regarding cellul...

Narmeen Ayaz, K. Parveen, Arooj Ali et al. · 0 citations
Open access Sep 2026

Evaluation of Ki-67 Labeling Index Across Histopathological Grades of Oral Squamous Cell Carcinoma

Objective: Oral squamous cell carcinoma (OSCC) is one of the most common malignancies of the oral cavity and remains a major cause of morbidity and mortality, particularly in developing countries. Although histopathological grading is routinely used to assess tumor differentiation, it may not accurately reflect the bio...

Jain Monika, Niharika Rawat, S. Jain et al. · 0 citations
Review Open access Sep 2026

Evaluation of GATA3 and HER-2 Immunohistochemical Expression as Prognostic Markers in Urothelial Carcinoma of the Urinary Bladder.

OBJECTIVE Urothelial carcinoma (UC) of the bladder remains a significant clinical challenge due to its high rates of recurrence and progression. Reliable biomarkers to predict tumor behaviour are still needed. GATA3 and HER2 have gained attention in this context, but their combined prognostic value has not been fully e...

M. Mohammed, Nehal Selim Abouhashim, M. Elfeky · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.